| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/21/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 1.8% stake in IO Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in Generation Bio Co. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 0.7% stake in Jounce Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 0% stake in Outset Medical, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3% stake in Adaptimmune Therapeutics PLC |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 5.9% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3.7% stake in Arcus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in uniQure N.V. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 7.3% stake in Caribou Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3.2% stake in Axsome Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 8.7% stake in ESSA Pharma Inc. |
| 01/17/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/17/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/10/2022 |
SC 13G
| PFM Health Sciences, LP reports a 8.7% stake in ESSA Pharma, Inc. |
| 10/24/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/17/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.5% stake in Arcus Biosciences, Inc. |
| 09/06/2022 |
SC 13G
| PFM Health Sciences, LP reports a 6.3% stake in Erasca, Inc. |
| 09/06/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.1% stake in Generation Bio Co. |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/17/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.4% stake in Praxis Precision Medicines, Inc. |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/09/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.8% stake in Adaptimmune Therapeutics PLC |
| 05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/25/2022 |
SC 13G
| PFM Health Sciences, LP reports a 5.2% stake in IO Biotech, Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 2.3% stake in Aerie Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 6.2% stake in Outset Medical, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in Arcus Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 7.8% stake in Jounce Therapeutics, Inc. |
|